Biomatest and GMHI in Colombia with InnerBuddies, Astrolab and EAFIT

Biomatest and the Gut Microbiome Health Index (GMHI) in Colombia

Biomatest is a gut microbiome testing and reporting tool developed through research at Universidad EAFIT in Medellín, Colombia, and advanced through collaboration with Astrolab and InnerBuddies. In simple terms, Biomatest helps analyze a person’s gut microbial community and translate the findings into a more understandable gut health report. The project is closely tied to the Gut Microbiome Health Index (GMHI), which is designed to turn complex microbiome data into a clear score and interpretation.

This article explains what Biomatest is, how it works, what the GMHI can show, and how the collaboration aims to add more practical guidance such as personalized nutrition advice. The current rollout is connected to Colombia and the partner organizations involved in the research and product development.

What is Biomatest?

Biomatest is a diagnostic and analysis tool focused on the gut microbiome. It uses scientific methods such as metagenomic sequencing and untargeted metabolomics to study the microbes in a biological sample and the metabolites associated with their activity. The goal is to generate a report that helps users better understand patterns linked to gut microbiome balance, diversity, and function.

Rather than presenting microbiome data in a highly technical format, Biomatest is intended to make the results easier to interpret. This can help support broader conversations about digestive health, metabolism, and other wellness-related topics, without replacing medical diagnosis or treatment.

How Biomatest works

Biomatest follows a straightforward workflow designed to move from sample to report:

• Sample collection: A biological sample is collected according to the test protocol.
• Processing: The sample is prepared for laboratory analysis using microbiome-focused methods.
• Analysis: Metagenomic sequencing and metabolomic analysis are used to study microbial composition and related metabolic signals.
• Interpretation: The results are organized into a clear report that can include the GMHI score and supporting microbiome metrics.
• Results and guidance: The platform can be expanded with educational context and personalized nutrition-oriented recommendations where appropriate.

This process is meant to make gut microbiome information more accessible for consumers, researchers, and B2B partners working in microbiome health.

What is the Gut Microbiome Health Index (GMHI)?

The Gut Microbiome Health Index (GMHI) is a scoring approach developed at Universidad EAFIT to summarize gut microbiome health in a simpler format. It translates microbiome composition and diversity into a single index score, helping users see how their gut profile compares across the system used in the report.

The GMHI is not a diagnosis. Instead, it is a way to organize complex data into a more understandable format that may support insights into digestive health, metabolic patterns, and immune-related topics. Depending on the report design, the index may also highlight potential signals that warrant further discussion with a qualified healthcare professional.

What you get from a Biomatest report

While the exact format may vary by version and partner implementation, a Biomatest-based report is designed to provide useful, easy-to-read microbiome information. Typical deliverables may include:

• A GMHI score: A clear index number that summarizes the gut microbiome health profile.
• Microbiome metrics: Information on composition, diversity, and other relevant microbial patterns.
• Interpretation summary: Plain-language context that helps explain what the findings may mean.
• Personalized nutrition guidance: Platform-based suggestions that may help support better dietary decision-making.
• Probiotics and prebiotics guidance: Educational recommendations where included in the product experience.
• Age-specific versions: In the current timeline, an adult version and a youth version are planned.

For consumers, the value of the report is not just the raw microbiome data, but the way it is turned into a more understandable health index and practical next steps.

About the collaboration between InnerBuddies, Astrolab and EAFIT

InnerBuddies is working with Astrolab Biotecnología and Universidad EAFIT to support the next generation of Biomatest and the Gut Microbiome Health Index (GMHI). The collaboration is intended to combine research, product development, and practical platform features in one ecosystem.

• The new version of Astrolab’s Biomatest product is being built on the InnerBuddies platform.
• InnerBuddies will integrate Astrolab/EAFIT’s GMHI into its platform for broader use.
• The partners will work on scientific innovation, clinical trials, research, and publications.
• InnerBuddies and Astrolab will develop the next generation of GMHI using new InnerBuddies-side developments.

According to the collaboration plan, the GMHI will be available not only to Astrolab customers but also to other InnerBuddies B2B customers worldwide, while the product and research foundation remains strongly connected to Colombia.

Why this matters for microbiome health education

Gut microbiome testing can be difficult to understand when the results are presented only as scientific data. Biomatest and GMHI are designed to make those findings more usable by combining advanced lab methods with a clearer interpretation layer.

For users, this means the report may help support a better understanding of how gut microbial patterns relate to topics like diet, digestion, metabolism, and general wellbeing. For researchers and partners, it creates a framework for expanding microbiome education and developing more user-friendly reporting tools.

Timeline and availability

The Gut Microbiome Health Index (GMHI) is planned to become available to InnerBuddies B2C and B2B customers in March 2025. The report is expected to show a simple score from 0 to 100, with higher numbers representing a healthier gut microbiome profile within the system used by the index.

The planned release includes both an adult version and a youth version for users under 18. Availability may vary by partner, market, and rollout stage, including Colombia and other regions served through InnerBuddies and Astrolab.

Frequently asked questions about Biomatest and GMHI

Is Biomatest a medical diagnosis?

No. Biomatest is a microbiome analysis and reporting tool. It may support health understanding, but it does not diagnose, treat, or cure disease.

What makes GMHI different from a standard gut test?

GMHI is designed to convert complex microbiome information into a simpler health index score. This can make the results easier to review alongside other wellness information.

Where is this project based?

The research and development are connected to Universidad EAFIT in Medellín, Colombia, with collaboration from Astrolab and InnerBuddies.

Will users get nutrition guidance?

The next version of Biomatest is expected to include personalized nutrition advice and related guidance within the platform experience.

Who can access GMHI?

According to the collaboration, GMHI will be available to Astrolab customers and other InnerBuddies B2B customers, with broader rollout plans tied to the platform.

Final thoughts

Biomatest and the Gut Microbiome Health Index represent a step toward making microbiome science more understandable and useful for everyday users. Through the collaboration between InnerBuddies, Astrolab, and Universidad EAFIT in Colombia, the project combines metagenomic sequencing, untargeted metabolomics, and clearer reporting to support better microbiome education and platform-based insights.